TG THERAPEUTICS INC

$TGTX
Smart money positioned

11 of the Top-200 alpha managers hold $TGTX as of the latest 13F snapshot.

13F holders
361
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

11 holders · Q1 2026

$TGTX is held by 11 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 5.42%, with an average of 0.61% of portfolio. Largest holder: Soleus Capital Management, L.P. at 5.42%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 361 · Source: 13F-HR
01
Axa S.a.
0.01% of portfolio
8,649,766 sh
02
State Street
0.01% of portfolio
8,479,999 sh
03
Banyan Capital Management, Inc.
6,331,716 sh
04
Exor N.V.
0.01% of portfolio
4,658,724 sh
05
Certuity, LLC
5.42% of portfolio
4,029,319 sh
06
Bank of Nova Scotia Trust Co.
0.09% of portfolio
3,210,930 sh
07
Bahl & Gaynor Inc.
2,979,285 sh
08
Brightline Capital Management, LLC
0.01% of portfolio
2,939,700 sh
09
Gates Foundation Trust
0.01% of portfolio
2,710,152 sh
10
Dean Investment Associates, LLC
0.52% of portfolio
2,168,081 sh
See all 361 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $TGTX in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $TGTX in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 06:03 UTC.